To navigate this increasingly complex environment in 2025, pharma manufacturers must fundamentally rethink their models and ...

One of the most strategic moves a pharmaceutical company can make is to establish an evidence generation plan early in the ...

A team of chemists from Scripps Research and Rice University has unveiled a novel method to simplify the synthesis of ...

Robust process development is essential in pharmaceutical manufacturing, optimizing drug discovery and ensuring regulatory ...

Traws Pharma shares surged 83% after the company disclosed progress in the development of tivoxavir marboxil as a treatment for HSN1 bird flu. Shares jumped to $9.16. The stock is down 73% on the year ...

In a time when pharmaceutical companies no longer have the economic luxury of decades-long development cycles, indication ...

Pfizer PFE issued its financial guidance for 2025. Sanofi SNY and Teva Pharmaceutical’s TEVA inflammatory bowel disease (IBD) ...

With a little more certainty coming to the market, the R&D environment in 2025 will be about pipeline prioritization and ...

Three-quarters of pharma and life sciences executives said they were optimistic for 2025, even though they expect some level ...

The pharmaceutical industry is poised for significant changes that could not only make drug development faster and more ...